Operational Implementation of Prospective Genotyping for Personalized Medicine: The Design of the Vanderbilt PREDICT Project
Published 2012 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Operational Implementation of Prospective Genotyping for Personalized Medicine: The Design of the Vanderbilt PREDICT Project
Authors
Keywords
-
Journal
CLINICAL PHARMACOLOGY & THERAPEUTICS
Volume 92, Issue 1, Pages 87-95
Publisher
Springer Nature
Online
2012-05-16
DOI
10.1038/clpt.2011.371
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Clinical Events as a Function of Proton Pump Inhibitor Use, Clopidogrel Use, and Cytochrome P450 2C19 Genotype in a Large Nationwide Cohort of Acute Myocardial Infarction
- (2011) Tabassome Simon et al. CIRCULATION
- Predicting Clopidogrel Response Using DNA Samples Linked to an Electronic Health Record
- (2011) J T Delaney et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Platelet Inhibition by Adjunctive Cilostazol Versus High Maintenance-Dose Clopidogrel in Patients With Acute Myocardial Infarction According to Cytochrome P450 2C19 Genotype
- (2011) In-Suk Kim et al. JACC-Cardiovascular Interventions
- High Doses of Clopidogrel to Overcome Genetic Resistance
- (2011) Jean-Philippe Collet et al. JACC-Cardiovascular Interventions
- Prasugrel Overcomes High On-Clopidogrel Platelet Reactivity Post-Stenting More Effectively Than High-Dose (150-mg) Clopidogrel
- (2011) Dimitrios Alexopoulos et al. JACC-Cardiovascular Interventions
- Standard- vs High-Dose Clopidogrel Based on Platelet Function Testing After Percutaneous Coronary Intervention
- (2011) Matthew J. Price JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- MyHealthAtVanderbilt: policies and procedures governing patient portal functionality
- (2011) C. Y. Osborn et al. JOURNAL OF THE AMERICAN MEDICAL INFORMATICS ASSOCIATION
- Charting a course for genomic medicine from base pairs to bedside
- (2011) Eric D. Green et al. NATURE
- Biomedical Informatics: Changing What Physicians Need to Know and How They Learn
- (2010) William W. Stead et al. ACADEMIC MEDICINE
- ACCF/AHA Clopidogrel Clinical Alert: Approaches to the FDA “Boxed Warning”
- (2010) et al. CIRCULATION
- Cytochrome 2C19*17 Allelic Variant, Platelet Aggregation, Bleeding Events, and Stent Thrombosis in Clopidogrel-Treated Patients With Coronary Stent Placement
- (2010) Dirk Sibbing et al. CIRCULATION
- First Analysis of the Relation Between CYP2C19 Genotype and Pharmacodynamics in Patients Treated With Ticagrelor Versus Clopidogrel
- (2010) Udaya S. Tantry et al. Circulation-Cardiovascular Genetics
- CYP2C19*2 and CYP2C9*3 alleles are associated with stent thrombosis: a case-control study
- (2010) A. M. Harmsze et al. EUROPEAN HEART JOURNAL
- Reduced-Function CYP2C19 Genotype and Risk of Adverse Clinical Outcomes Among Patients Treated With Clopidogrel Predominantly for PCI
- (2010) Jessica L. Mega et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Clopidogrel and the Reduced-Function CYP2C19 Genetic Variant
- (2010) Valentin Fuster et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Review Article: Combination of Clopidogrel and Proton Pump Inhibitors: Implications for Clinicians
- (2010) Marie Tran et al. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY AND THERAPEUTICS
- Antiplatelet drug interactions
- (2010) I. S. Mackenzie et al. JOURNAL OF INTERNAL MEDICINE
- The Case for Routine Genotyping in Dual-Antiplatelet Therapy
- (2010) Samir B. Damani et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Cardiovascular Risk in Clopidogrel-Treated Patients According to Cytochrome P450 2C19*2 Loss-of-Function Allele or Proton Pump Inhibitor Coadministration
- (2010) Jean-Sébastien Hulot et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Clopidogrel Loading Dose Adjustment According to Platelet Reactivity Monitoring in Patients Carrying the 2C19*2Loss of Function Polymorphism
- (2010) Laurent Bonello et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Genetic variants in ABCB1 and CYP2C19 and cardiovascular outcomes after treatment with clopidogrel and prasugrel in the TRITON–TIMI 38 trial: a pharmacogenetic analysis
- (2010) Jessica L Mega et al. LANCET
- Effects ofCYP2C19Genotype on Outcomes of Clopidogrel Treatment
- (2010) Guillaume Paré et al. NEW ENGLAND JOURNAL OF MEDICINE
- The Path to Personalized Medicine
- (2010) Margaret A. Hamburg et al. NEW ENGLAND JOURNAL OF MEDICINE
- DNA, drugs and chariots: on a decade of pharmacogenomics at the US FDA
- (2010) Lawrence J Lesko et al. PHARMACOGENOMICS
- Association of Cytochrome P450 2C19 Genotype With the Antiplatelet Effect and Clinical Efficacy of Clopidogrel Therapy
- (2009) Alan R. Shuldiner JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Opportunities and Challenges for the NIH — An Interview with Francis Collins
- (2009) Robert Steinbrook NEW ENGLAND JOURNAL OF MEDICINE
- Pharmacogenetics — Tailoring Treatment for the Outliers
- (2009) Janet Woodcock et al. NEW ENGLAND JOURNAL OF MEDICINE
- Assessing Patient Readiness for the Clinical Adoption of Personalized Medicine
- (2009) A.M. Issa et al. Public Health Genomics
- Development of a Large-Scale De-Identified DNA Biobank to Enable Personalized Medicine
- (2008) DM Roden et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Cytochrome P450 2C19 polymorphism in young patients treated with clopidogrel after myocardial infarction: a cohort study
- (2008) Jean-Philippe Collet et al. LANCET
- Cytochrome P-450 Polymorphisms and Response to Clopidogrel
- (2008) Jessica L. Mega et al. NEW ENGLAND JOURNAL OF MEDICINE
- Genetic Determinants of Response to Clopidogrel and Cardiovascular Events
- (2008) Tabassome Simon et al. NEW ENGLAND JOURNAL OF MEDICINE
- Pharmacogenomic Biomarker Information in Drug Labels Approved by the United States Food and Drug Administration: Prevalence of Related Drug Use
- (2008) Felix W Frueh et al. PHARMACOTHERAPY
- ‘I’m Happy if I Can Help’
- (2008) Janine M. Traulsen et al. Public Health Genomics
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation